In its "Members Alert" issue for January, 2001 (Vol. 5, No. 7 -- see copy of front copy at left, or see enlargement), the monthly publication, Health Sciences Institute Members Alert, published a front page article entitled, "Billion-dollar drug company nearly squashes astounding research on natural cancer killer." Since the botanical plant that is the source of the article, Graviola, is an active component in our new Cansema Tonic III, we reproduce excerpts from this article below.
"Two months ago, we learned about an astounding cancer-fighting tree from the Amazon that has literally sent shock waves through the HSI network.
"Today, the future of cancer treatment and the chances for survival look more promising than ever. There's a healing tree that grows deep within the Amazon rain forest in South America that could literally change how you, your doctor, and possibly the rest of the world think about curing cancer. With extracts from this powerful tree, it may now be possible to ...
Graviola is 10,000 times stronger in killing colon cancer than Adriamycin, a commonly used chemotherapeutic drug.
"The answer to these difficult questions can only be explained by recounting a disturbing story we recently uncovered. More than anything else we've reported on this year, the story of this Amazon cancer treatment reinforces the need for groups like HSI and illustrates how easily our options for medical treatment are controlled by money and power.
"A confidential source, whose account we've been able to independently confirm, revealed that a billion-dollar drug company in the United States tried for nearly seven years to synthesize two of the tree's most powerful anticancerous chemicals. In the early 1990's, behind lock and key, this well-known drug giant began searching for a cure for cancer -- while preciously guarding their opportunity to patent it and, therefore, profit from it.
"Research focused on a legendary healing tree called Graviola. Parts of the tree -- including the bark, leaves, roots, fruit, and fruit seeds -- had been used for centuries by medicine men and native Indians in South America to treat heart disease, asthma, liver problems, and arthritis. Going on little documented scientific evidence, the company poured money and resources into testing Graviola's anticancerous properties -- and they were shocked with the results. Graviola was a cancer-killing dynamo. But that's where the story of Graviola nearly ended.
"The pharmaceutical company had a big problem. They'd spent years trying to isolate and create man-made duplicates of two of the three's most powerful chemicals. But they'd hit a brick wall. They couldn't replicate the original. And they couldn't sell the tree extract itself profitably -- because federal law mandates that natural substances can't be patented. That meant the company couldn't protect its profits on the project it had poured millions of dollars and nearly seven years of research into.
testing on Graviola came to a screeching halt
"After seven frustrating years and without the promise of lucrative sales, the company shelved the project and refused to publish its findings in an independent journal. But one responsible researcher struggled with the decision. While understanding the company's goal of profits, he couldn't accept the decision to hide this unique cancer killer from the world. Following his conscience and risking his career, he contacted (an Amazonian harvester of botanicals)...
"As a result, (the harvester) went into high gear and began to research related studies published on Graviola. They discovered that several other teams in the United States (in addition to that of the drug company) had been testing Graviola in vitro (in test tubes). The results supported the drug company's secret findings: Graviola had been shown to kill cancer cells...
lung, breast, colon, and pancreatic cancer...
leaving healthy cells alone
"Since November, we've been looking closely into the research to date on Graviola. It appears one of the first scientific references to it in the United States was the National Cancer Institute (NCI). In 1976, the NCI included Graviola in a plant-screening program that showed its leaves and stems were effective in attacking and destroying malignant cells. But the results were part of an internal NCI report and were, for some reason, never released to the public (1). [AO Editor: Sound familiar?]
"Since 1976, there have been several promising cancer studies on Graviola. However, the tree's extracts have yet to be tested on cancer patients. No double-blind clinical trials exist, and clinical trials are typically the benchmark mainstream doctors and journals use to judge a treatment's value. Nevertheless, Graviola has been shown to kill cancer cells in vitro in at least 20 laboratory tests that our research has uncovered.
"The most recent study, conducted at Catholic University of South Korea earlier this year, revealed that two chemicals extracted from Graviola seeds showed "selective cytotoxicity comparable with Adriamycin" for breast and colon cancer cells. The chemicals targeted and killed malignant breast and colon cells in a test tube -- comparable to the commonly used chemotherapy drug Adriamycin (2).
"Another study, published in the JOurnal of Natural Products, showed that Graviola is not only comparable to Adriamycin -- but dramatically outperforms it in laboratory tests. Results showed that one chemical found in Graviola selectively killed colon cancer cells at "10,000 times the potency of Adriamycin." (3).
"Other promising and ongoing research at Purdue University is supported by a grant from the National Cancer Institute. Purdue researchers recently found that leaves from the Graviola tree killed cancer cells "among six human-cell lines" and were especially effective against prostate and pancreatic cancer cells. (4). In a separate study, Purdue researchers showed that extracts from the Graviola leaves are extremely effective in isolating and killing lung cancer cells. (5).
"Perhaps the most significant result of the study cited above from the Catholic University of South Korea, and of each of the others we've found, is that Graviola was shown to selectively target the enemy -- leaving all healthy, normal cells untouched. [AO Editor: Alpha Omega customers are accustomed to this phenomenon, as the entire Cansema product line exhibits this property.] By comparison, chemotherapy indiscriminately seeks and destroys all actively reproducing cells -- even normal hair and stomach cells. This is what causes such often-devastating side effects, such as hair loss and severe nausea. In this respect, Graviola looks to be a promising alternative or supplement to mainstream treatments..."
AO Editor Comments
This is not the end of the article.
HSI goes on to discuss patient reports using a Graviola product ("N-Tense") from Raintree Nutrition, which has its own extensive web page on Graviola -- a delight for those who want an in-depth study on this botanical. In addition, HSI covers the implications of government coverup -- which regular Alpha Omega customers have known about for years.
Our contribution to Graviola is its inclusion of Cansema Tonic III using a proprietary process that extracts the active components into aloe, which is highly bioavailable -- more so than even tonics in which water or alcohol is the primary substrate. We are in the process of presenting our own case studies in Graviola, using Cansema Tonic III, which will be published on this site in the coming weeks to show the efficacy of our approach as they are completed.
1 -- Unpublished data, National Cancer Institute, Anon: Nat Cancer Ist Central Files -- (1978) from Napreiert Files, University of Illinois, 1995.
2 -- Bioorg Med Chem 8(1): 285-90, 2000
3 -- J Nat Prod 59(2):100-108, 1996
4 -- Phytochemistry 49(2):565-71, 1998
5 -- J Nat Prod 58(6):902-908, 1995